23andMe filed for bankruptcy amid financial struggles and fallout after a data breach. Now, potential buyers and investors are weighing the value of its DNA database. One of the world's largest troves ...
Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...
The settlement highlights the lasting risks of exposing genetic data that can’t be changed or replaced.
Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...
Add Yahoo as a preferred source to see more of our stories on Google. New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of ...
Remember when everyone was discovering they were 12% Scandinavian and posting colorful pie charts of their genetic heritage on social media? Those glory days of DNA testing have come to a stunning end ...
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...
Wojcicki launched TTAM earlier this year with the specific goal of keeping 23andMe’s genetic data of about 15 million users out of the hands of third parties like biotech firm Regeneron, which bid ...
NewsNation on MSN
CIA explored 23andMe, Ancestry for alien DNA links: Whistleblower
The Remote Viewing Program probed whether people could use extrasensory perception to conduct recon.
Following a data breach and bankruptcy, genetic testing service 23andMe will soon be in different hands. On Monday, biotechnology company Regeneron announced that it won the top bid in a bankruptcy ...
Regeneron Pharmaceuticals has acquired 23andMe – and the genetic data for 15 million customers along with it. Credit: Tiffany Hagler-Geard/Bloomberg via Getty Images 23andMe had all the signs of a ...
The assets of failed DNA testing firm 23andMe are being bought for $256 million. Biotechnology firm Regeneron Pharmaceuticals said on Monday it would acquire 23andMe's personal genome service, total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results